Meiogenix is currently owned by Sofinnova Partners, through Sofinnova Industrial Biotech, since 2019.

When did Sofinnova Partners acquire Meiogenix?

Sofinnova Partners acquired Meiogenix in 2019 (active for 7 years).

Home/Companies/Biotech/Meiogenix

Meiogenix

Biotech·

France·Active·7yr hold

Meiogenix is a healthcare company, headquartered in France.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Most recent investor

Sofinnova Partners

2 ownership periods

Key facts

HQFrance

SectorHealthcare

French company applying gene and chromosome editing technologies to solve key challenges in agriculture and industrial applications.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings